期刊文献+

化疗相关性腹泻的治疗 被引量:2

原文传递
导出
摘要 化疗相关性腹泻(Chemotherapy-Induced Di-arrhea,CID)是肿瘤患者在化疗中常见的并发症,不仅会降低患者的生活质量,还会增加患者住院费用和治疗时间,严重者还可能会导致水和电解质失衡,血容量减少,化疗被迫中断,更甚者休克甚至危及生命。与其他化疗引起的消化道反应如恶心、呕吐相比,CID的发病机制至今尚未完全清楚,其治疗方案也不同于一般性腹泻。
出处 《中国煤炭工业医学杂志》 2012年第8期1297-1299,共3页 Chinese Journal of Coal Industry Medicine
  • 相关文献

参考文献14

二级参考文献40

  • 1王曦钟,吕益中,梁水权,李耀峰.微生态制剂与胃肠粘膜屏障[J].中国基层医药,2005,12(2):217-218. 被引量:16
  • 2杨凤杰,焦登鳌,李申影.肠道菌群与大肠癌[J].中华流行病学杂志,1996,17(1):52-54. 被引量:2
  • 3傅冷西,戴起宝.大肠癌肠粘膜菌群分析[J].中华消化杂志,1996,16(2):114-115. 被引量:3
  • 4陈敏聪.厌氧菌及其感染[M].上海:上海医科大学出版社,1989.12-14.
  • 5能德鑫.厌氧菌的分离和鉴定[M].南昌:江西科学技术出版社,1986.127.
  • 6田爪正气.两种细菌可能与长寿有关.日本医学介绍,1990,11(10):461-461.
  • 7Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis,2001,1(2) :101.
  • 8Hopkins M J, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut,2001,48(2) :198.
  • 9Hebuterne X. Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metab Care .2003,6( 1 ) :49.
  • 10Kornblan S, Benin AB, Catalano R, et al, Management of cancertreatment - related diarrhea : issue and therapeutic st rategies[J]. J Pain and Symptom Management,2000,19(2):118.

共引文献180

同被引文献35

  • 1Wang M, Cao JX, Liu YS, et al. Evaluation of tumour vaccine immunotherapy for the treatment of advanced non - small cell lung cancer: a systematic meta- analysis [J]. BMJ Open, 2015, 5 (4) : e006321.
  • 2Umihanic S, Umihanic S, Jamakosmanovic S, et al. Glasgow prog- nostic score in patients receiving chemotherapy for non - small - cell lung cancer in stages ]lib and IV[J]. Med Arch, 2014, 68(2) . 83 - 85.
  • 3Chen M, Zhang J, Yu S, et al. Anti - lung - cancer activity and liposome- based delivery systems of [3 -elemene[ J]. Evid Based Complement Altemat Med, 2012, 2012: 259523.
  • 4Calixto - Lima L, de Andrade EM, Gomes AP, et al. Dietetic management in gastrointestinal complications from antimalignant chemotherapy[ J]. Nutr Hosp, 2012, 27 ( 1 ) : 65 - 75.
  • 5Elsheshtawy EA, Abo -Elez WF, Ashour I/S, et al. Coping stra- tegies in egyptian ladies with breast cancer[J].Breast Cancer (Auckl), 2014, 8: 97- 102.
  • 6美国卫生及公共服务部,国立卫生研究院,国家癌症研究所.常见不良反事件评价标准4.0版[EB/OL].(2015-07-05)[2015-08-10].http://www.doc88.com/p一6406716494402.html.
  • 7Liu Y, Yu S, Liu S, et al. Comparison of nedaplatin - based ver- sus cisplatin - based chemotherapy for advanced non - small cell lung cancer among East Asian populations: a meta- analysis[J].Sci Rep, 2015, 5: 10516.
  • 8Boussios S, Pentheroudakis G, Katsanos K, et al. Systemic treat- ment- induced gastrointestinal toxicity: incidence, clinical pres-entation and management[ J]. Ann Gastroenterol, 2012, 25 (2) 106 - 118.
  • 9Ishikawa A, Ohara G, Nakazawa K, et al. Chemotherapy - in- duced complications in patients with lung cancer: an evaluation by pharmacists[ J]. Mol Clin Oncol, 2013, 1 ( 1 ) : 65 - 68.
  • 10Surendiran A, Balamurugan N, Gunasedan K, et al. Adverse drug reaction profile of cisplatin - based chemotherapy regimen in a tertiary care hospital in India: an evaluative study[ J]. Indian J Pbarmacol, 2010, 42(1) : 40 -43.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部